Longmaster Info-tech(300288)

Search documents
朗玛信息(300288) - 2021 Q1 - 季度财报
2021-04-23 16:00
[Important Notice](index=2&type=section&id=Item%201.%20Important%20Notice) This section serves as the declaration for the quarterly report, with the Board of Directors, Supervisory Board, and senior management guaranteeing the report's truthfulness, accuracy, and completeness, and assuming legal responsibility - The company's Board of Directors, Supervisory Board, and senior management guarantee the truthfulness, accuracy, and completeness of the quarterly report, free from false statements, misleading representations, or major omissions, and assume individual and joint legal liabilities[3](index=3&type=chunk) - Company head Wang Wei, chief accounting officer Wang Chun, and head of accounting department Ma Yong declare the truthfulness, accuracy, and completeness of the financial statements in the quarterly report[4](index=4&type=chunk) [Company Profile](index=3&type=section&id=Item%202.%20Company%20Profile) This section outlines the company's key accounting data and financial indicators for the reporting period, detailing the total number of shareholders and the top ten shareholders' holdings, including their nature, shareholding percentage, and share status [Major Accounting Data and Financial Indicators](index=3&type=section&id=Item%202.1.%20Major%20Accounting%20Data%20and%20Financial%20Indicators) The company demonstrated strong financial performance in Q1 2021, with operating revenue growing by 16.03%, net profit attributable to shareholders increasing by 173.77%, and net cash flow from operating activities rising by 71.24% Financial Performance Indicators | Indicator | Current Period (RMB) | Prior Period (RMB) | YoY Change (%) | | :--- | :--- | :--- | :--- | | Operating Revenue | 96,922,308.96 | 83,529,822.18 | 16.03% | | Net Profit Attributable to Shareholders of Listed Company | 18,308,621.43 | 6,687,713.16 | 173.77% | | Net Profit Attributable to Shareholders of Listed Company (Excluding Non-Recurring Gains/Losses) | 16,171,399.80 | 5,167,804.35 | 212.93% | | Net Cash Flow from Operating Activities | 15,977,579.96 | 9,330,316.14 | 71.24% | | Basic Earnings Per Share (RMB/share) | 0.0542 | 0.0198 | 173.74% | | Diluted Earnings Per Share (RMB/share) | 0.0542 | 0.0198 | 173.74% | | Weighted Average Return on Net Assets | 1.29% | 0.49% | 0.80% | Balance Sheet Indicators | Indicator | End of Current Period (RMB) | End of Prior Year (RMB) | Change from Prior Year-End (%) | | :--- | :--- | :--- | :--- | | Total Assets | 1,920,764,617.56 | 1,877,352,042.58 | 2.31% | | Net Assets Attributable to Shareholders of Listed Company | 1,435,816,026.78 | 1,411,762,774.61 | 1.70% | Non-Recurring Gains and Losses | Item | Amount from Year-Start to End of Reporting Period (RMB) | Explanation | | :--- | :--- | :--- | | Government Grants Recognized in Current Profit/Loss | 3,144,538.06 | Government grants obtained in prior periods allocated to profit/loss in the current period, and income-related government grants obtained in the current period | | Other Non-Operating Income and Expenses (Excluding Above) | -912,489.84 | | | Less: Income Tax Impact | 378,814.70 | | | Impact of Minority Interests (After Tax) | -283,988.11 | | | Total | 2,137,221.63 | -- | [Total Number of Shareholders and Top Ten Shareholders' Holdings at the End of the Reporting Period](index=4&type=section&id=Item%202.2.%20Total%20Number%20of%20Shareholders%20and%20Top%20Ten%20Shareholders'%20Holdings%20at%20the%20End%20of%20the%20Reporting%20Period) As of the end of the reporting period, the company had 30,751 common shareholders, with Wang Wei, the controlling shareholder, holding 35.36% of shares, a significant portion of which are restricted, and acting in concert with Guiyang Langma Investment Consulting Enterprise (Limited Partnership) - Total number of common shareholders at the end of the reporting period: **30,751**[11](index=11&type=chunk) Top Ten Shareholders' Holdings | Shareholder Name | Shareholder Nature | Shareholding Percentage | Number of Shares Held (shares) | Number of Restricted Shares Held (shares) | | :--- | :--- | :--- | :--- | :--- | | Wang Wei | Domestic Natural Person | 35.36% | 119,496,015 | 89,622,011 | | Jin Guowen | Domestic Natural Person | 5.93% | 20,042,611 | 0 | | Liu Ling | Domestic Natural Person | 4.19% | 14,145,602 | 0 | | Huang Guohong | Domestic Natural Person | 2.84% | 9,587,399 | 0 | | Guiyang Langma Investment Consulting Enterprise (Limited Partnership) | Domestic Non-State-Owned Legal Person | 2.45% | 8,285,640 | 0 | - The company's corporate shareholder, Guiyang Langma Investment Consulting Enterprise (Limited Partnership), is controlled by the company's controlling shareholder and actual controller, Wang Wei, and they are parties acting in concert[12](index=12&type=chunk) [Significant Events](index=6&type=section&id=Item%203.%20Significant%20Events) This section details the reasons for significant changes in major financial data and indicators, reviews business segment operations and future strategies, discloses progress on private share placement, and confirms no overdue unfulfilled commitments or illegal guarantees [Significant Changes in Major Financial Data and Indicators and Their Reasons During the Reporting Period](index=6&type=section&id=Item%203.1.%20Significant%20Changes%20in%20Major%20Financial%20Data%20and%20Indicators%20and%20Their%20Reasons%20During%20the%20Reporting%20Period) This section explains the reasons for significant changes in various key financial data within the balance sheet, income statement, and cash flow statement for Q1 2021, including contract assets, right-of-use assets, taxes payable, financial expenses, and investment income [Balance Sheet Items](index=6&type=section&id=Item%203.1.1.%20Balance%20Sheet%20Items) During the reporting period, contract assets increased by 45.77% due to unbilled settlement revenue; right-of-use assets and lease liabilities were newly recognized for office building leases; taxes payable grew by 68.79% due to subsidiary tax increases - The ending balance of contract assets increased by **45.77%** compared to the beginning of the year, primarily due to unbilled settlement revenue from "Phone-to-Phone" and IPTV services[15](index=15&type=chunk) - The ending balance of right-of-use assets was **RMB 6,891,939.23**, mainly due to the recognition of right-of-use assets for office buildings leased by the company and its subsidiaries[15](index=15&type=chunk) - The ending balance of taxes payable increased by **68.79%** compared to the beginning of the year, primarily due to increased taxes for Guiyang Langma Communication Technology Co., Ltd. and Guangzhou Qisheng Information Technology Co., Ltd[15](index=15&type=chunk) [Income Statement Items](index=6&type=section&id=Item%203.1.2.%20Income%20Statement%20Items) Financial expenses decreased by 39.38% due to reduced loans; other income increased by 69.44% from government grants; investment income decreased by 49.63% due to lower net profit from an associate; credit impairment losses decreased by 93.7% due to reduced bad debt provisions - Financial expenses decreased by **39.38%** year-on-year, mainly due to reduced interest expenses resulting from a decrease in loan balances[16](index=16&type=chunk) - Other income increased by **69.44%** year-on-year, primarily due to income-related government grants received in the current period and those allocated from prior periods[16](index=16&type=chunk) - Investment income decreased by **49.63%** year-on-year, mainly due to a decrease in net profit from the associate, Guiyang City Medical E-commerce Service Co., Ltd[16](index=16&type=chunk) - Credit impairment losses decreased by **93.7%** year-on-year, primarily due to a reduction in bad debt provisions for accounts receivable in the current period[16](index=16&type=chunk) - Non-operating income decreased by **84.74%** year-on-year, mainly because the controlling subsidiary, Guiyang City Sixth Hospital Co., Ltd., had pandemic donation income in the prior period[16](index=16&type=chunk) [Cash Flow Items](index=7&type=section&id=Item%203.1.3.%20Cash%20Flow%20Items) Net cash flow from operating activities increased by 71.24% due to higher sales; net cash flow from investing activities decreased by 251.33% due to increased subsidiary project expenditures; net cash flow from financing activities increased by 858.45% from bank loans and minority shareholder investments - Net cash flow from operating activities increased by **71.24%** year-on-year, primarily due to increased sales revenue leading to higher collections[18](index=18&type=chunk) - Net cash flow from investing activities decreased by **251.33%** year-on-year, mainly due to project expenditures by Liuyi Company in the current period[18](index=18&type=chunk) - Net cash flow from financing activities increased by **858.45%** year-on-year, primarily due to bank loans and minority shareholder investments in Guiyang Langma Vision Technology Co., Ltd. in the current period[18](index=18&type=chunk) [Business Review and Outlook](index=7&type=section&id=Item%203.2.%20Business%20Review%20and%20Outlook) In Q1 2021, all business segments showed positive development, with significant growth in operating revenue and net profit, as the company continues to deepen its "Internet + Healthcare" strategy and build the "39" internet healthcare brand - In Q1 2021, the company achieved operating revenue of **RMB 96.9223 million**, a year-on-year increase of **16.03%**; net profit attributable to shareholders was **RMB 18.3086 million**, a year-on-year increase of **173.77%**[19](index=19&type=chunk) Operating Revenue by Business Segment | Business Segment | Operating Revenue (RMB 10k) | YoY Growth (%) | | :--- | :--- | :--- | | Telecom Value-Added Services and IPTV Home Smart Healthcare Business | 347.22 | - | | Mobile Resale Business (Langma Communication) | 2,414.49 | 44.39% | | Healthcare Information Services (Guangzhou Qisheng) | 3,042.45 | 27.10% | | Guiyang City Sixth Hospital Co., Ltd. | 3,797.35 | 6.71% | | Guiyang City Medical E-commerce Service Co., Ltd. | 67,920.83 | 12.5% | - The company will continue to deepen its "Internet + Healthcare" strategy, accelerate the improvement of the Langma Internet Healthcare ecosystem, focus on building the "39" internet healthcare brand, and form an internet healthcare industry cluster to break down regional barriers and support the implementation of national hierarchical diagnosis and treatment through internet healthcare models[20](index=20&type=chunk) [Analysis of Progress, Impact, and Solutions for Significant Events](index=9&type=section&id=Item%203.3.%20Analysis%20of%20Progress%2C%20Impact%2C%20and%20Solutions%20for%20Significant%20Events) The company received approval from the China Securities Regulatory Commission on September 28, 2020, for the private placement of shares, and the Board of Directors will proceed with the issuance in accordance with the approval and legal requirements - On September 28, 2020, the company received the "Approval for the Registration of Private Placement of Shares by Guiyang Langma Information Technology Co., Ltd." (CSRC Permit [2020] No. 2329) issued by the China Securities Regulatory Commission[23](index=23&type=chunk) - The company's Board of Directors will handle the relevant matters for this private placement of shares within the prescribed period, in accordance with the approval document, relevant laws and regulations, and the authorization of the company's general meeting of shareholders[23](index=23&type=chunk) [Overdue Unfulfilled Commitments](index=9&type=section&id=Item%203.4.%20Overdue%20Unfulfilled%20Commitments) During the reporting period, there were no overdue unfulfilled commitments by the company's actual controller, shareholders, related parties, acquirers, or the company itself - During the reporting period, the company had no overdue unfulfilled commitments by its actual controller, shareholders, related parties, acquirers, or the company itself[24](index=24&type=chunk) [Comparison Table of Funds Raised Usage](index=9&type=section&id=Item%203.5.%20Comparison%20Table%20of%20Funds%20Raised%20Usage) The comparison table of funds raised usage is not applicable for this reporting period - The comparison table of funds raised usage is not applicable[25](index=25&type=chunk) [Warning of Significant Changes in Cumulative Net Profit](index=10&type=section&id=Item%203.6.%20Warning%20of%20Significant%20Changes%20in%20Cumulative%20Net%20Profit) The company has no warning regarding a potential loss or significant change in cumulative net profit from the beginning of the year to the end of the next reporting period - During the reporting period, the company has no warning or explanation regarding a potential loss or significant change in cumulative net profit from the beginning of the year to the end of the next reporting period[26](index=26&type=chunk) [Illegal External Guarantees](index=10&type=section&id=Item%203.7.%20Illegal%20External%20Guarantees) The company had no illegal external guarantees during the reporting period - The company had no illegal external guarantees during the reporting period[26](index=26&type=chunk) [Non-Operating Fund Occupation by Controlling Shareholder and Related Parties](index=10&type=section&id=Item%203.8.%20Non-Operating%20Fund%20Occupation%20by%20Controlling%20Shareholder%20and%20Related%20Parties) During the reporting period, there was no non-operating fund occupation by the controlling shareholder or its related parties - During the reporting period, there was no non-operating fund occupation by the controlling shareholder or its related parties of the listed company[27](index=27&type=chunk) [Registration Form for Investor Relations Activities](index=10&type=section&id=Item%203.9.%20Registration%20Form%20for%20Investor%20Relations%20Activities) The company did not host any investor relations activities such as research visits, communications, or interviews during the reporting period - The company did not host any investor relations activities such as research visits, communications, or interviews during the reporting period[28](index=28&type=chunk) [Financial Statements](index=11&type=section&id=Item%204.%20Financial%20Statements) This section presents the consolidated and parent company financial statements for Guiyang Langma Information Technology Co., Ltd. for Q1 2021, including the balance sheet, income statement, and cash flow statement, along with explanations for adjustments due to the first-time adoption of new lease standards [Financial Statements](index=11&type=section&id=Item%204.1.%20Financial%20Statements) This part includes the company's consolidated and parent company balance sheets, income statements, and cash flow statements for Q1 2021, comprehensively presenting the financial position and operating results at the end of the reporting period [Consolidated Balance Sheet](index=11&type=section&id=Item%204.1.1.%20Consolidated%20Balance%20Sheet) As of March 31, 2021, the company's consolidated total assets were RMB 1,920,764,617.56, total liabilities were RMB 445,823,646.70, and total owners' equity was RMB 1,474,940,970.86 | Item | March 31, 2021 (RMB) | December 31, 2020 (RMB) | | :--- | :--- | :--- | | Total Assets | 1,920,764,617.56 | 1,877,352,042.58 | | Total Liabilities | 445,823,646.70 | 426,742,858.47 | | Total Owners' Equity | 1,474,940,970.86 | 1,450,609,184.11 | [Parent Company Balance Sheet](index=14&type=section&id=Item%204.1.2.%20Parent%20Company%20Balance%20Sheet) As of March 31, 2021, the parent company's total assets were RMB 1,600,500,033.46, total liabilities were RMB 234,764,956.45, and total owners' equity was RMB 1,365,735,077.01 | Item | March 31, 2021 (RMB) | December 31, 2020 (RMB) | | :--- | :--- | :--- | | Total Assets | 1,600,500,033.46 | 1,596,482,785.27 | | Total Liabilities | 234,764,956.45 | 230,484,284.80 | | Total Owners' Equity | 1,365,735,077.01 | 1,365,998,500.47 | [Consolidated Income Statement](index=17&type=section&id=Item%204.1.3.%20Consolidated%20Income%20Statement) In Q1 2021, the company's consolidated total operating revenue was RMB 96,922,308.96, net profit was RMB 16,786,194.59, and net profit attributable to parent company shareholders was RMB 18,308,621.43 | Item | Current Period (RMB) | Prior Period (RMB) | | :--- | :--- | :--- | | Total Operating Revenue | 96,922,308.96 | 83,529,822.18 | | Total Operating Costs | 79,656,666.07 | 81,494,318.16 | | Operating Profit | 22,585,040.17 | 7,123,897.99 | | Total Profit | 21,672,550.33 | 7,265,526.99 | | Net Profit | 16,786,194.59 | 4,825,018.19 | | Net Profit Attributable to Parent Company Shareholders | 18,308,621.43 | 6,687,713.16 | | Basic Earnings Per Share | 0.0542 | 0.0198 | [Parent Company Income Statement](index=19&type=section&id=Item%204.1.4.%20Parent%20Company%20Income%20Statement) In Q1 2021, the parent company's operating revenue was RMB 9,224,050.49, and net profit was -RMB 263,423.46, showing a narrowed loss compared to the prior period | Item | Current Period (RMB) | Prior Period (RMB) | | :--- | :--- | :--- | | Operating Revenue | 9,224,050.49 | 13,996,507.03 | | Operating Profit | -710,905.74 | -2,932,650.53 | | Total Profit | -705,718.56 | -2,932,650.53 | | Net Profit | -263,423.46 | -1,784,841.21 | [Consolidated Cash Flow Statement](index=21&type=section&id=Item%204.1.5.%20Consolidated%20Cash%20Flow%20Statement) In Q1 2021, consolidated net cash flow from operating activities was RMB 15,977,579.96, from investing activities was -RMB 780,978.76, from financing activities was RMB 21,464,580.49, and the net increase in cash and cash equivalents was RMB 36,661,181.69 | Item | Current Period (RMB) | Prior Period (RMB) | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 15,977,579.96 | 9,330,316.14 | | Net Cash Flow from Investing Activities | -780,978.76 | -222,289.77 | | Net Cash Flow from Financing Activities | 21,464,580.49 | -2,830,046.11 | | Net Increase in Cash and Cash Equivalents | 36,661,181.69 | 6,277,980.26 | | Cash and Cash Equivalents at Period End | 431,235,512.64 | 358,911,968.97 | [Parent Company Cash Flow Statement](index=23&type=section&id=Item%204.1.6.%20Parent%20Company%20Cash%20Flow%20Statement) In Q1 2021, parent company net cash flow from operating activities was -RMB 1,635,520.10, from investing activities was -RMB 3,242,653.98, from financing activities was RMB 2,792,350.21, and the net increase in cash and cash equivalents was -RMB 2,085,823.87 | Item | Current Period (RMB) | Prior Period (RMB) | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | -1,635,520.10 | -6,446,364.00 | | Net Cash Flow from Investing Activities | -3,242,653.98 | -299,137.00 | | Net Cash Flow from Financing Activities | 2,792,350.21 | -2,287,433.33 | | Net Increase in Cash and Cash Equivalents | -2,085,823.87 | -9,032,934.33 | | Cash and Cash Equivalents at Period End | 131,319,528.73 | 160,316,856.86 | [Explanation of Financial Statement Adjustments](index=25&type=section&id=Item%204.2.%20Explanation%20of%20Financial%20Statement%20Adjustments) This section explains the impact of the first-time adoption of new lease standards on the financial statements from 2021, primarily involving adjustments to the consolidated balance sheet, while the parent company balance sheet remained unaffected [Adjustments for First-Time Adoption of New Lease Standards](index=25&type=section&id=Item%204.2.1.%20Adjustments%20for%20First-Time%20Adoption%20of%20New%20Lease%20Standards) Due to the first-time adoption of new lease standards, the company adjusted its consolidated balance sheet as of January 1, 2021, reclassifying rent payable from "Other Payables" to "Lease Liabilities," with no adjustments to the parent company balance sheet - Rent payable of **RMB 603,069.72** by Guizhou Laya Technology Co., Ltd. was reclassified from other payables to lease liabilities[58](index=58&type=chunk) - No adjustments were made to the parent company balance sheet[60](index=60&type=chunk) [Explanation of Retrospective Adjustments for New Lease Standards](index=28&type=section&id=Item%204.2.2.%20Explanation%20of%20Retrospective%20Adjustments%20for%20New%20Lease%20Standards) The company adopted new lease standards for the first time in 2021 but did not retrospectively adjust prior comparative data - The explanation of retrospective adjustments for prior comparative data under the new lease standards from 2021 is not applicable[61](index=61&type=chunk) [Audit Report](index=28&type=section&id=Item%204.3.%20Audit%20Report) The company's first-quarter report for 2021 is unaudited - The company's first-quarter report is unaudited[61](index=61&type=chunk)
朗玛信息(300288) - 2020 Q4 - 年度财报
2021-04-23 16:00
贵阳朗玛信息技术股份有限公司 2020 年年度报告全文 贵阳朗玛信息技术股份有限公司 2020 年年度报告 2021 年 04 月 1 贵阳朗玛信息技术股份有限公司 2020 年年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真 实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和 连带的法律责任。 公司负责人王伟、主管会计工作负责人王春及会计机构负责人(会计主管人 员)马勇声明:保证本年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本报告中如有涉及未来发展计划等前瞻性陈述,属于计划性事项,不构成 公司对投资者的实质承诺。投资者及相关人士均应当对此保持足够的风险认识, 并且应当理解计划、预测与承诺之间的差异,请投资者注意投资风险。 公司在本报告"第四节经营情况讨论与分析"之"九、公司未来发展的展 望"中详细描述了公司经营中可能存在的风险和应对措施,敬请广大投资者关 注相关内容。 公司经本次董事会审议通过的利润分配预案为:以 337,941,402 为基数,向 全体股东每 10 股派发现金红利 0.15 ...
朗玛信息(300288) - 2020 Q3 - 季度财报
2020-10-29 16:00
贵阳朗玛信息技术股份有限公司 2020 年第三季度报告全文 1 贵阳朗玛信息技术股份有限公司 2020 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人王伟、主管会计工作负责人王春及会计机构负责人(会计主管人 员)马勇声明:保证季度报告中财务报表的真实、准确、完整。 2 贵阳朗玛信息技术股份有限公司 2020 年第三季度报告全文 贵阳朗玛信息技术股份有限公司 2020 年第三季度报告 2020 年 10 月 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末 | | --- | --- | --- | --- | --- | | | | | | 增减 | | 总资产(元) | 1,880,585,308.74 | | 1,856,177,613.28 | 1.31% | | 归属于上市公司股东的 ...
朗玛信息(300288) - 2020 Q2 - 季度财报
2020-08-26 16:00
贵阳朗玛信息技术股份有限公司 2020 年半年度报告 2020 年 08 月 贵阳朗玛信息技术股份有限公司 2020 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的 真实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别 和连带的法律责任。 公司负责人王伟、主管会计工作负责人王春及会计机构负责人(会计主管人 员)马勇声明:保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本报告如有涉及未来计划等前瞻性陈述,属于计划性事项,均不构成公司 对投资者的实质承诺。投资者及相关人士均应当对此保持足够的风险认识,并 且应当理解计划、预测与承诺之间的差异。 公司在发展的过程中面临市场竞争加剧及产业政策变化的行业风险、公司 资产规模扩大带来的管理及运营风险、商誉减值的风险等诸多风险因素,公司 在本报告第四节"经营情况讨论与分析"之"九、公司面临的风险和应对措施"部 分,详细描述了公司经营中可能存在的风险及应对措施,敬请投资者关注相关 内容。 公司计划不派发现金红利,不送红股,不以公积金转增股本。 1 | ...
朗玛信息(300288) - 2020 Q1 - 季度财报
2020-04-27 16:00
贵阳朗玛信息技术股份有限公司 2020 年第一季度报告全文 贵阳朗玛信息技术股份有限公司 2020 年第一季度报告 2020 年 04 月 贵阳朗玛信息技术股份有限公司 2020 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人王伟、主管会计工作负责人王春及会计机构负责人(会计主管人 员)马勇声明:保证季度报告中财务报表的真实、准确、完整。 1 2 贵阳朗玛信息技术股份有限公司 2020 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同 | | --- | --- | --- | --- | | | | | 期增减 | | 营业总收入(元) | 83,529,822.18 | 115,110,413.66 | -27.44% | | 归属于上市公司股东的净利润(元) | 6,687, ...
朗玛信息(300288) - 2019 Q4 - 年度财报
2020-04-23 16:00
贵阳朗玛信息技术股份有限公司 2019 年年度报告全文 贵阳朗玛信息技术股份有限公司 2019 年年度报告 2020 年 04 月 1 贵阳朗玛信息技术股份有限公司 2019 年年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真 实、准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担个别和连 带的法律责任。 公司负责人王伟、主管会计工作负责人王春及会计机构负责人(会计主管人 员)马勇声明:保证年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本年度报告如有涉及未来计划等前瞻性陈述,属于计划性事项,均不构成 公司对投资者的实质承诺。投资者及相关人士均应当对此保持足够的风险认识, 并且应当理解计划、预测与承诺之间的差异。 1、市场竞争加剧风险 中国整体宏观环境的变化、社会老龄化的到来,医疗健康服务业将成为未 来国民经济的亮点。国家医疗卫生体制改革进一步深化,"互联网+医疗"战略 的提出,更使得互联网医疗成为投资界的"风口"。诸多资金的涌入,特别是 医药行业大公司涉足互联网、互联网巨头在医疗健康领域的布局,使得互联网 ...
朗玛信息(300288) - 2019 Q4 - 年度财报
2020-04-23 16:00
[Important Notice, Table of Contents, and Definitions](index=2&type=section&id=Item%20I.%20Important%20Notice%2C%20Table%20of%20Contents%2C%20and%20Definitions) This section provides an important notice regarding the annual report's authenticity, accuracy, and completeness, along with definitions of key terms [Important Notice](index=2&type=section&id=Important%20Notice) This chapter emphasizes the truthfulness, accuracy, and completeness of the annual report content, and discloses the main risks faced by the company, including intensified market competition, changes in industrial policies, adjustments in telecom value-added services, management risks from asset expansion, and goodwill impairment risks - The company faces major operational risks including: - **Intensified market competition**: Capital influx into the internet healthcare industry, especially from large pharmaceutical companies and internet giants, intensifies market competition[5](index=5&type=chunk) - **Changes in industrial policies**: Due to the specificity of the healthcare industry and increasingly stringent regulatory environment, the company faces risks from policy adjustments and stricter supervision[6](index=6&type=chunk) - **Telecom value-added business adjustments**: Affected by operator business structure adjustments, the company's traditional "Phone Match" business revenue significantly declined, with development focus shifting to healthcare business[7](index=7&type=chunk) - **Management and operational risks**: The expansion of the company's assets and personnel scale imposes higher requirements on operational decisions, management operations, and risk control[8](index=8&type=chunk) - **Goodwill impairment risk**: The company's goodwill primarily stems from the 2014 acquisition of Qisheng Information; if Qisheng Information's operating performance declines in the future, it will lead to goodwill impairment risk; in 2019, Qisheng Information achieved a net profit of **RMB 75.48 million**, with no goodwill impairment occurring[10](index=10&type=chunk) - The company plans to non-publicly issue shares to raise no more than **RMB 283 million** for the functional upgrade and content expansion of its smart healthcare service platform, but this matter is subject to CSRC approval and carries uncertainty[11](index=11&type=chunk) - The company's 2019 profit distribution plan is: based on **337,941,402 shares**, a cash dividend of **RMB 0.21** (tax inclusive) per 10 shares will be distributed to all shareholders[11](index=11&type=chunk) [Definitions](index=6&type=section&id=Definitions) This chapter defines key terms and company entity abbreviations used in the report, such as "Phone Match", "39 Internet Hospital", "Qisheng Information", and "Liuyi Company", providing a basis for understanding the report content [Company Profile and Key Financial Indicators](index=7&type=section&id=Item%20II.%20Company%20Profile%20and%20Key%20Financial%20Indicators) This section presents the company's basic information and a summary of its key financial performance and position for the reporting period [Company Information](index=7&type=section&id=Company%20Information) This chapter provides the company's basic business registration information, contact details, and information disclosure channels Company Information | Item | Information | | :--- | :--- | | Stock Abbreviation | Longmaster Information | | Stock Code | 300288 | | Legal Representative | Wang Wei | | Registered Address | No. 31 Changling South Road, Jinyang Science and Technology Industrial Park, Guiyang National High-tech Industrial Development Zone, Guiyang City, Guizhou Province | | International Internet Website | www.longmaster.com.cn | [Key Accounting Data and Financial Indicators](index=8&type=section&id=Key%20Accounting%20Data%20and%20Financial%20Indicators) In 2019, the company's performance declined, with operating revenue decreasing by **4.89%** year-on-year, and net profit attributable to shareholders of the listed company decreasing by **36.87%** year-on-year; net cash flow from operating activities also decreased by **18.40%** year-on-year; despite an increase in total assets, profitability indicators such as return on net assets declined Key Financial Indicators | Key Financial Indicators | 2019 | 2018 | Year-on-Year Change | | :--- | :--- | :--- | :--- | | Operating Revenue (RMB) | 435,706,090.79 | 458,109,105.00 | -4.89% | | Net Profit Attributable to Shareholders of Listed Company (RMB) | 65,909,367.29 | 104,398,064.60 | -36.87% | | Net Profit Excluding Non-recurring Items (RMB) | 55,645,052.24 | 91,330,554.30 | -39.07% | | Net Cash Flow from Operating Activities (RMB) | 101,051,748.84 | 123,837,769.39 | -18.40% | | Basic Earnings Per Share (RMB/share) | 0.20 | 0.31 | -35.48% | | Weighted Average Return on Net Assets | 4.88% | 8.25% | -3.37% | | Total Assets (RMB) | 1,856,177,613.28 | 1,722,366,727.60 | 7.77% | | Net Assets Attributable to Shareholders of Listed Company (RMB) | 1,367,083,665.24 | 1,318,071,368.05 | 3.72% | 2019 Quarterly Financial Indicators | 2019 Quarterly Financial Indicators | Q1 | Q2 | Q3 | Q4 | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue (RMB) | 115,110,413.66 | 119,078,072.07 | 114,473,430.04 | 87,044,175.02 | | Net Profit Attributable to Parent Company (RMB) | 18,952,556.07 | 25,101,848.64 | 22,389,087.62 | -534,125.04 | - In 2019, the company's total non-recurring gains and losses amounted to **RMB 10.26 million**, primarily from government subsidies[25](index=25&type=chunk) [Business Overview](index=11&type=section&id=Item%20III.%20Business%20Overview) This section outlines the company's primary business segments, significant asset changes, and core competitive advantages [Main Businesses During the Reporting Period](index=11&type=section&id=Main%20Businesses%20During%20the%20Reporting%20Period) The company focuses on two major business segments: medical services + internet healthcare and telecom & telecom value-added services; the medical segment, relying on its physical hospital (Guiyang No. 6 Hospital), has built an ecosystem integrating medical information services, internet hospitals, IPTV health platforms, smart wearable devices, and pharmaceutical distribution; the telecom segment includes mobile resale and traditional "Phone Match" businesses, providing cash flow support for the company - The company's businesses are mainly divided into two segments: - **Medical Services + Internet Healthcare Business**: Deeply cultivates "Internet + Healthcare", relying on offline medical institutions to integrate and build the "39" internet healthcare brand, merging online and offline services[28](index=28&type=chunk)[29](index=29&type=chunk) - **Telecom and Telecom Value-Added Business**: Includes mobile resale business and "Phone Match" business, providing cash flow for the company's development[28](index=28&type=chunk)[37](index=37&type=chunk) - During the COVID-19 pandemic, the company utilized "Internet + Healthcare" technology to provide free remote consultation services to the public, aiming to alleviate pressure on physical medical institutions and reduce the risk of cross-infection[29](index=29&type=chunk) [Significant Changes in Major Assets](index=14&type=section&id=Significant%20Changes%20in%20Major%20Assets) During the reporting period, the company's major assets underwent significant changes; monetary funds increased substantially by **35.65%** due to cash retained from operating activities and bank loans; prepayments and deferred income tax assets also increased by **91.34%** and **68.06%** respectively; additionally, other non-current assets surged by **299.92%** due to prepaid medical equipment purchases Major Asset Changes | Major Assets | Period-end vs. Year-start Growth Rate | Explanation of Significant Change | | :--- | :--- | :--- | | Monetary Funds | 35.65% | Due to cash retained from operating activities and bank loans | | Prepayments | 91.34% | Due to prepaid telecom settlement fees by Longmaster Communication | | Deferred Income Tax Assets | 68.06% | Due to deductible temporary differences arising from tax losses | | Other Non-current Assets | 299.92% | Due to prepaid medical equipment purchases by Liuyi Company | [Analysis of Core Competencies](index=14&type=section&id=Analysis%20of%20Core%20Competencies) The company's core competencies are evident in multiple areas; in internet healthcare, the company emphasizes adherence to medical principles and possesses policy support, professional teams, medical resources, and technological advantages (e.g., AI imaging diagnosis); in information services, 39 Health Network boasts advantages in traffic, content, and resources; furthermore, the company has established solid competitive advantages in pharmaceutical distribution and telecom value-added services - **Internet Healthcare and Medical Services Competitiveness**: - **Adherence to medical principles**: Believes that the essence of internet healthcare is medical treatment, with the internet serving as a connector and amplifier[40](index=40&type=chunk) - **Policy support**: Business receives strong support from various levels of government in Guizhou Province[40](index=40&type=chunk) - **Team advantage**: Medical industry professionals and internet operation teams form a complementary advantage[41](index=41&type=chunk) - **Technological advantage**: Possesses technological accumulation in audio-video communication and AI imaging diagnosis[42](index=42&type=chunk) - **Internet Information Service Industry Competitiveness**: - 39 Health Network possesses advantages in traffic, content, resources, and talent, making it a leading health portal website in China[43](index=43&type=chunk) [Management Discussion and Analysis](index=17&type=section&id=Item%20IV.%20Management%20Discussion%20and%20Analysis) This section provides an overview of the company's operational performance, detailed analysis of its main business segments, R&D investments, cash flow, and future development outlook [Overview](index=17&type=section&id=Overview) In 2019, the company continued to focus on the big data and big health industry, forming an "Internet + Healthcare" service closed-loop supported by physical hospitals, and developing telecom businesses to ensure cash flow; the company was again selected among "China's Top 100 Internet Enterprises", rising to **35th** place; among its business segments, 39 Health Network's revenue slightly increased by **1.25%**, physical hospital Liuyi Company's revenue grew by **2.26%**, mobile resale business increased by **38.57%**, while traditional Phone Match business revenue significantly declined by **65.59%** due to operator policy changes - The company was again selected among "China's Top 100 Internet Enterprises" in 2019, rising from **39th** to **35th** place, making it the only "Internet + Healthcare" enterprise to be continuously selected for four years in China[53](index=53&type=chunk) Business Segment Performance | Business Segment | 2019 Revenue/Performance | Year-on-Year Change | | :--- | :--- | :--- | | 39 Health Network (Qisheng Information) | RMB 155.24 million | +1.25% | | Physical Hospital (Liuyi Company) | RMB 183.68 million | +2.26% | | Mobile Resale Business | RMB 58.30 million | +38.57% | | Phone Match Business | RMB 25.89 million | -65.59% | | Pharmaceutical Distribution Business (E-commerce) | RMB 2.61 billion | -4.52% | - In 2019, the physical hospital (Guiyang Liuyi) saw increases in total outpatient visits, inpatient numbers, and surgical procedures by **6.07%**, **2.45%**, and **6.55%** respectively, compared to the previous year[56](index=56&type=chunk) [Analysis of Main Business](index=22&type=section&id=Analysis%20of%20Main%20Business) In 2019, the company's total operating revenue was **RMB 436 million**, a **4.89%** year-on-year decrease; by product segment, medical services and medical information services are the main revenue sources, accounting for **41.45%** and **35.29%** respectively, both achieving slight growth; mobile resale business grew significantly (**+38.57%**), but traditional IPTV and Phone Match business revenue sharply declined (**-58.99%**); overall gross profit margin was **42.48%**, down **6.86** percentage points from the previous year, mainly due to the contraction of high-margin phone business and increased costs in lower-margin medical services Operating Revenue Composition (by Product) | Operating Revenue Composition (by Product) | 2019 Amount (RMB) | Proportion of Total Revenue | Year-on-Year Change | | :--- | :--- | :--- | :--- | | Medical Services | 180,598,892.81 | 41.45% | +2.62% | | Medical Information Services | 153,774,628.78 | 35.29% | +1.94% | | Mobile Resale Business | 58,297,300.47 | 13.38% | +38.57% | | IPTV Business and Phone Match Business | 31,751,472.43 | 7.29% | -58.99% | | **Total Operating Revenue** | **435,706,090.79** | **100%** | **-4.89%** | Gross Profit Margin of Main Products | Main Product Gross Profit Margin | 2019 Gross Profit Margin | Change in Gross Profit Margin from Previous Year | | :--- | :--- | :--- | | Medical Information Services | 79.66% | -3.90% | | IPTV Business and Phone Match Business | 78.99% | -9.79% | | Mobile Resale Business | 43.73% | +14.64% | | Medical Services | 4.54% | -3.40% | | **Total** | **42.48%** | **-6.86%** | Expense Items | Expense Item | 2019 Amount (RMB) | Year-on-Year Change | Explanation of Change | | :--- | :--- | :--- | :--- | | Selling Expenses | 19,204,737.60 | -28.92% | Decrease in Phone Match business volume, leading to reduced corresponding expenses | | Administrative Expenses | 79,309,698.06 | -4.36% | - | | Financial Expenses | 6,417,972.75 | 87.54% | Increase in interest due to increased borrowings in the current period | | R&D Expenses | 33,357,892.62 | -8.36% | - | [R&D Investment](index=27&type=section&id=R%26D%20Investment) The company continues to invest in R&D in the internet healthcare sector, with **RMB 33.36 million** invested in R&D in 2019, accounting for **7.66%** of operating revenue; R&D directions include cloud consultation service platforms, health management service platforms, smart healthcare family health service platforms, and medical informatization products; R&D investment as a percentage of revenue has remained between **7.5%** and **8%** over the past three years R&D Investment | R&D Investment | 2019 | 2018 | 2017 | | :--- | :--- | :--- | :--- | | R&D Investment Amount (RMB) | 33,357,892.62 | 36,401,121.77 | 33,053,246.28 | | R&D Investment as % of Operating Revenue | 7.66% | 7.95% | 8.03% | | Number of R&D Personnel (persons) | 207 | 235 | 230 | [Cash Flow](index=28&type=section&id=Cash%20Flow) In 2019, the company's net cash flow from operating activities was **RMB 101.05 million**, a **18.40%** year-on-year decrease; net cash outflow from investing activities significantly decreased by **52.59%**, mainly due to reduced capital expenditure on construction in progress by Liuyi Company; net cash inflow from financing activities increased by **52.69%**; ultimately, the net increase in cash and cash equivalents was **RMB 83.99 million**, a year-on-year increase of over **11** times, primarily driven by bank borrowings and retained operating cash Cash Flow Statement Items | Cash Flow Statement Item | 2019 (RMB) | 2018 (RMB) | Year-on-Year Change | | :--- | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 101,051,748.84 | 123,837,769.39 | -18.40% | | Net Cash Flow from Investing Activities | -72,935,215.34 | -153,834,794.96 | -52.59% | | Net Cash Flow from Financing Activities | 55,869,335.95 | 36,589,090.59 | 52.69% | | Net Increase in Cash and Cash Equivalents | 83,985,869.45 | 6,592,065.02 | 1,174.04% | [Outlook for Company's Future Development](index=33&type=section&id=Outlook%20for%20Company%27s%20Future%20Development) The company will continue to focus on the medical + internet business segment, building the "39" internet healthcare brand; key development areas include exploring the integration of 39 Health Network with online businesses, advancing the upgrade and construction of Guiyang Liuyi physical hospital to create a smart hospital demonstration, developing chronic disease management based on the "39 Health Medical Service Platform", assisting grassroots medical institutions through remote medical models, and stabilizing telecom value-added businesses to ensure cash flow - The company faces major risks including external competition, business innovation, exploration of scaled profitability, and talent shortage[96](index=96&type=chunk) - **2020 Key Initiatives**: - **39 Health Network**: Build vertical content integrated marketing capabilities and promote new media productization[98](index=98&type=chunk) - **Guiyang Liuyi**: Advance physical hospital upgrades, build smart hospitals, and create a national internet hospital demonstration[98](index=98&type=chunk) - **39 Health Medical Service Platform**: Explore chronic disease management product systems and develop chronic disease management services based on smart wearable devices[99](index=99&type=chunk) - **Remote Medical Care**: Provide specialized department construction solutions for county-level and private hospitals through "mobile internet + on-site" models[99](index=99&type=chunk) - **Telecom Business**: Stabilize telecom value-added businesses and expand mobile resale business to ensure cash flow for company development[100](index=100&type=chunk)[101](index=101&type=chunk) [Significant Events](index=36&type=section&id=Item%20V.%20Significant%20Events) This section details important corporate events including profit distribution, major litigation, related-party transactions, and social responsibility initiatives [Profit Distribution and Capital Reserve Conversion to Share Capital](index=36&type=section&id=Profit%20Distribution%20and%20Capital%20Reserve%20Conversion%20to%20Share%20Capital) The company's 2019 profit distribution plan is a cash dividend of **RMB 0.21** (tax inclusive) per 10 shares, totaling **RMB 7.10 million**, accounting for **10.77%** of the net profit attributable to the parent company for the year; over the past three years, cash dividends were distributed in 2018, but not in 2017 Cash Dividends | Dividend Year | Cash Dividend Amount (Tax Inclusive, RMB) | Ratio to Net Profit Attributable to Parent Company in Consolidated Statements | | :--- | :--- | :--- | | 2019 | 7,096,769.44 | 10.77% | | 2018 | 16,897,070.10 | 16.19% | | 2017 | 0.00 | 0.00% | [Major Litigation and Arbitration Matters](index=44&type=section&id=Major%20Litigation%20and%20Arbitration%20Matters) During the reporting period, the company's controlling subsidiary, Guiyang No. 6 Hospital Co., Ltd., was involved in a construction contract dispute with Guizhou Jian Gong Group Sixth Construction Engineering Co., Ltd., with the case amount reaching **RMB 76.90 million**, and the case is still under trial - Controlling subsidiary Guiyang No. 6 Hospital Co., Ltd. was sued due to a construction contract dispute, involving **RMB 76.90 million**, and the case is currently in litigation[123](index=123&type=chunk) [Major Related-Party Transactions](index=45&type=section&id=Major%20Related-Party%20Transactions) During the reporting period, the company's routine related-party transactions primarily involved its controlling subsidiary, Liuyi Company, purchasing pharmaceuticals and medical consumables from related party Guiyang City Pharmaceutical E-commerce Service Co., Ltd., with a transaction amount of **RMB 42.75 million**; additionally, Liuyi Company had website maintenance and labor cooperation with related party Guiyang Sanjiu Internet Medical Co., Ltd Related-Party Transactions | Related Party | Related Transaction Content | Related Transaction Amount (RMB million) | | :--- | :--- | :--- | | Guiyang City Pharmaceutical E-commerce Service Co., Ltd. | Purchase of pharmaceuticals, medical consumables, etc. | 42.75 | | Guiyang Sanjiu Internet Medical Co., Ltd. | Website maintenance and labor | 4.72 | [Social Responsibility](index=51&type=section&id=Social%20Responsibility) The company actively fulfills its social responsibilities, especially during the COVID-19 pandemic, where its 39 Internet Hospital, 39 Health Network, and other platforms jointly launched free remote medical consultation activities, accumulating a huge service volume; additionally, the company continued to carry out "Internet + Medical Poverty Alleviation" work in various parts of Guizhou, providing assistance through industrial, educational, and health initiatives, investing **RMB 0.16 million** in poverty alleviation funds in 2019 - In response to the COVID-19 pandemic, the company, in collaboration with China Volunteer Doctors and other organizations, launched a free remote consultation platform, accumulating over **8,000** video consultations and over **50,000** text consultations, with the pandemic special topic generating over **400 million** total traffic[144](index=144&type=chunk)[145](index=145&type=chunk) - The company continued to carry out targeted poverty alleviation work, investing **RMB 0.16 million** in poverty alleviation funds in 2019, providing medical and health assistance in Nayong County, Xishui County, and other areas of Guizhou Province, helping **35** registered impoverished individuals escape poverty[148](index=148&type=chunk)[149](index=149&type=chunk) [Share Changes and Shareholder Information](index=56&type=section&id=Item%20VI.%20Share%20Changes%20and%20Shareholder%20Information) This section covers changes in the company's share capital structure and provides details on its shareholders and actual controller [Share Change Information](index=56&type=section&id=Share%20Change%20Information) During the reporting period, the company's total share capital of **337,941,402 shares** remained unchanged; due to executive departures and position changes, restricted shares increased by **4,449,025 shares**, and unrestricted shares decreased accordingly, leading to an increase in the restricted share ratio from **38.80%** to **40.12%** Share Changes | Share Class | Before This Change | After This Change | Reason for Change | | :--- | :--- | :--- | :--- | | Restricted Shares | 131,124,889 | 135,573,914 | Share lock-up changes due to executive departures and resignations | | Unrestricted Shares | 206,816,513 | 202,367,488 | Corresponding adjustment | | **Total Share Capital** | **337,941,402** | **337,941,402** | **Unchanged** | [Shareholders and Actual Controller Information](index=58&type=section&id=Shareholders%20and%20Actual%20Controller%20Information) As of the end of the reporting period, the company had a total of **33,823** common shareholders; the actual controller, Mr. Wang Wei, directly holds **36.36%** of the shares and indirectly holds shares through Guiyang Longmaster Investment Consulting Enterprise (Limited Partnership) which he controls, collectively controlling **37.81%** of the company's shares; among the top ten shareholders, besides Wang Wei and his concerted parties, all are natural person shareholders or private equity funds - As of the end of 2019, the company had a total of **33,823** shareholders[163](index=163&type=chunk) Top Five Shareholders | Top Five Shareholders | Shareholder Nature | Shareholding Ratio | Number of Shares Held | | :--- | :--- | :--- | :--- | | Wang Wei | Domestic Natural Person | 36.36% | 119,496,015 | | Jin Guowen | Domestic Natural Person | 7.11% | 24,036,100 | | Liu Ling | Domestic Natural Person | 4.53% | 15,312,900 | | Huang Guohong | Domestic Natural Person | 4.44% | 14,991,086 | | Guiyang Longmaster Investment Consulting Enterprise (Limited Partnership) | Domestic Non-State-Owned Legal Person | 2.45% | 8,285,640 | - The company's controlling shareholder and actual controller is Mr. Wang Wei; he and Guiyang Longmaster Investment Consulting Enterprise (Limited Partnership) are concerted parties, collectively controlling **37.81%** of the company's shares[164](index=164&type=chunk)[664](index=664&type=chunk) [Directors, Supervisors, Senior Management, and Employees](index=65&type=section&id=Item%20IX.%20Directors%2C%20Supervisors%2C%20Senior%20Management%2C%20and%20Employees) This section provides information on the shareholdings, remuneration, and overall composition of the company's directors, supervisors, senior management, and employees [Shareholding Changes of Directors, Supervisors, and Senior Management](index=65&type=section&id=Shareholding%20Changes%20of%20Directors%2C%20Supervisors%2C%20and%20Senior%20Management) During the reporting period, company Chairman Wang Wei reduced his holdings by approximately **3 million shares**, and Vice Chairman Huang Guohong reduced his holdings by approximately **4.99 million shares**; Director and Deputy General Manager Jin Guowen's shareholding status changed due to his departure, but the total number of shares remained unchanged; the total shares held by directors, supervisors, and senior management decreased from **167 million shares** at the beginning of the period to **159 million shares** at the end of the period Shareholding Changes of Directors, Supervisors, and Senior Management | Name | Position | Shares Held at Beginning of Period (shares) | Shares Reduced in Current Period (shares) | Shares Held at End of Period (shares) | | :--- | :--- | :--- | :--- | :--- | | Wang Wei | Chairman | 122,496,000 | 2,999,985 | 119,496,015 | | Huang Guohong | Vice Chairman (Departed) | 19,981,086 | 4,990,000 | 14,991,086 | | Jin Guowen | Director, Deputy General Manager (Departed) | 24,036,100 | 0 | 24,036,100 | [Remuneration of Directors, Supervisors, and Senior Management](index=72&type=section&id=Remuneration%20of%20Directors%2C%20Supervisors%2C%20and%20Senior%20Management) In 2019, the total pre-tax remuneration received by the company's directors, supervisors, and senior management was **RMB 8.50 million**; among them, Chairman Mr. Wang Wei's remuneration was the highest at **RMB 1.51 million**, and Director and General Manager Mr. Wang Jian's was **RMB 1.23 million**; the stipends for the three independent directors were all **RMB 0.12 million** - In 2019, the total pre-tax remuneration received by the company's directors, supervisors, and senior management was **RMB 8.50 million**[195](index=195&type=chunk) [Employee Information](index=73&type=section&id=Employee%20Information) As of the end of the reporting period, the company had a total of **1,187** active employees; by professional composition, medical and nursing staff accounted for the largest proportion at **568** people, followed by technical personnel (**207** people) and administrative personnel (**159** people); in terms of education level, employees with a bachelor's degree or above accounted for more than half Employee Professional Composition | Professional Composition | Number of Persons (persons) | | :--- | :--- | | Medical and Nursing Staff | 568 | | Technical Personnel | 207 | | Administrative Personnel | 159 | | Sales Personnel | 127 | | Customer Service Personnel | 87 | | Financial Personnel | 38 | | Production Personnel | 1 | | **Total** | **1,187** | [Corporate Governance](index=75&type=section&id=Item%20X.%20Corporate%20Governance) This section describes the company's corporate governance framework, its compliance with regulatory requirements, and the status of its internal control system [Basic Status of Corporate Governance](index=75&type=section&id=Basic%20Status%20of%20Corporate%20Governance) The company has established a governance structure with clear responsibilities and standardized operations, consisting of the general meeting of shareholders, board of directors, supervisory board, and senior management, in accordance with the "Company Law" and other regulations; the actual corporate governance status complies with relevant regulatory provisions, maintaining "five independences" from the controlling shareholder in terms of business, personnel, assets, organization, and finance - The actual corporate governance status complies with the requirements of the "Guidelines for Corporate Governance of Listed Companies" and the "Guidelines for Standardized Operation of Companies Listed on the ChiNext Board of Shenzhen Stock Exchange"[204](index=204&type=chunk) - The company maintains "five independences" from its controlling shareholder in terms of business, personnel, assets, organization, and finance[205](index=205&type=chunk) [Internal Control Evaluation Report](index=78&type=section&id=Internal%20Control%20Evaluation%20Report) According to the company's internal control self-evaluation report, the total assets and operating revenue of the units included in the evaluation scope both accounted for **100%** of the consolidated financial statements; during the reporting period, the company found no material weaknesses or significant deficiencies in internal control related to financial and non-financial reporting Internal Control Defect Status | Internal Control Defect Status | Number (units) | | :--- | :--- | | Material Weaknesses in Financial Reporting | 0 | | Material Weaknesses in Non-Financial Reporting | 0 | | Significant Deficiencies in Financial Reporting | 0 | | Significant Deficiencies in Non-Financial Reporting | 0 | [Financial Report](index=82&type=section&id=Item%20XII.%20Financial%20Report) This section includes the independent auditor's report, the company's consolidated and parent company financial statements, and detailed notes to the financial statements [Audit Report](index=82&type=section&id=Audit%20Report) Dahua Certified Public Accountants issued a standard unqualified audit opinion on the company's 2019 financial statements; the audit report specifically highlighted two key audit matters: revenue recognition and goodwill impairment, considering both to involve significant management judgment and estimation, posing potential risks of material misstatement - The audit firm issued a standard unqualified audit opinion[221](index=221&type=chunk) - Key audit matters are: 1. **Revenue Recognition**: As operating revenue is a significant financial indicator, management's judgment and presentation in revenue recognition may pose a significant risk of material misstatement[225](index=225&type=chunk)[226](index=226&type=chunk) 2. **Goodwill Impairment**: As of the end of 2019, the carrying value of goodwill accounted for **30.72%** of total assets, which is material, and impairment testing involves significant management judgment and estimation[225](index=225&type=chunk)[227](index=227&type=chunk) [Financial Statements](index=87&type=section&id=Financial%20Statements) This chapter provides the company's consolidated and parent company balance sheets, income statements, cash flow statements, and statements of changes in owners' equity for the year 2019; key data shows that the company's total assets increased from **RMB 1.72 billion** to **RMB 1.86 billion**, but net profit decreased from **RMB 104 million** to **RMB 66 million** Key Items from Consolidated Balance Sheet | Key Items from Consolidated Balance Sheet | December 31, 2019 (RMB) | December 31, 2018 (RMB) | | :--- | :--- | :--- | | Total Assets | 1,856,177,613.28 | 1,722,366,727.60 | | Total Liabilities | 440,486,121.44 | 348,754,796.46 | | Total Owners' Equity Attributable to Parent Company | 1,367,083,665.24 | 1,318,071,368.05 | Key Items from Consolidated Income Statement | Key Items from Consolidated Income Statement | 2019 (RMB) | 2018 (RMB) | | :--- | :--- | :--- | | Total Operating Revenue | 435,706,090.79 | 458,109,105.00 | | Operating Profit | 72,836,336.74 | 108,832,131.73 | | Total Profit | 72,795,558.52 | 111,174,797.21 | | Net Profit Attributable to Parent Company Owners | 65,909,367.29 | 104,398,064.60 | [Notes to Consolidated Financial Statement Items](index=157&type=section&id=Notes%20to%20Consolidated%20Financial%20Statement%20Items) This chapter provides detailed explanations of major items in the consolidated financial statements; as of the end of the period, **RMB 21.79 million** of the company's monetary funds were judicially frozen due to litigation; the original carrying value of goodwill was **RMB 580 million**, primarily from the acquisition of Guangzhou Qisheng Information, with a total goodwill impairment of **RMB 4.75 million** recognized for Guiyang No. 6 Hospital and Guizhou Laya Technology in the current period; among long-term equity investments, the investment in associate Guiyang City Pharmaceutical E-commerce Service Co., Ltd. had the highest carrying value at **RMB 285 million** - As of the end of the period, **RMB 21.79 million** of the company's monetary funds were judicially frozen due to litigation[437](index=437&type=chunk) Goodwill Impairment Provision | Goodwill Impairment Provision | Beginning Balance (RMB) | Provision in Current Period (RMB) | Ending Balance (RMB) | | :--- | :--- | :--- | :--- | | Guiyang No. 6 Hospital Co., Ltd. | 4,627,139.97 | 1,846,674.07 | 6,473,814.04 | | Guizhou Laya Technology Co., Ltd. | 0.00 | 2,906,794.03 | 2,906,794.03 | | **Total** | **4,627,139.97** | **4,753,468.10** | **9,380,608.07** | - Full impairment provision was recognized for the goodwill of Guizhou Laya Technology Co., Ltd. because it has not yet obtained a medical device production license, and its operating situation has significant uncertainties[511](index=511&type=chunk) - The total government subsidies received by the company in 2019 and recognized in current profit or loss amounted to **RMB 11.84 million**[741](index=741&type=chunk)
朗玛信息(300288) - 2019 Q3 - 季度财报
2019-10-24 16:00
贵阳朗玛信息技术股份有限公司 2019 年第三季度报告全文 贵阳朗玛信息技术股份有限公司 2019 年第三季度报告 2019 年 10 月 1 贵阳朗玛信息技术股份有限公司 2019 年第三季度报告全文 第一节 重要提示 2 贵阳朗玛信息技术股份有限公司 2019 年第三季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末 | | --- | --- | --- | --- | --- | | | | | | 增减 | | 总资产(元) | 1,910,159,125.83 | | 1,722,366,727.60 | 10.90% | | 归属于上市公司股东的净资 产(元) | 1,367,617,790.28 | | 1,318,071,368.05 | 3.76% | | | 本报告期 | 本报告期比上年同 | 年初至报告期末 | 年初至报告期末比 | | | | 期增减 | | 上年同期增减 | | 营业收入(元) | 114,473,430.04 | -5.53% | ...
朗玛信息(300288) - 2019 Q2 - 季度财报
2019-08-28 16:00
[Important Notice, Table of Contents, and Definitions](index=2&type=section&id=%E7%AC%AC%E4%B8%80%E8%8A%82%20%E9%87%8D%E8%A6%81%E6%8F%90%E7%A4%BA%E3%80%81%E7%9B%AE%E5%BD%95%E5%92%8C%E9%87%8A%E4%B9%89) [Company Profile and Key Financial Indicators](index=5&type=section&id=%E7%AC%AC%E4%BA%8C%E8%8A%82%20%E5%85%AC%E5%8F%B8%E7%AE%80%E4%BB%8B%E5%92%8C%E4%B8%BB%E8%A6%81%E8%B4%A2%E5%8A%A1%E6%8C%87%E6%A0%87) [Company Profile](index=5&type=section&id=%E4%B8%80%E3%80%81%E5%85%AC%E5%8F%B8%E7%AE%80%E4%BB%8B) This section provides the company's basic business registration information, including its stock ticker "Longma Information", stock code "300288", full Chinese and English names, legal representative, and contact details | Item | Information | | :--- | :--- | | **Stock Abbreviation** | Longma Information | | **Stock Code** | 300288 | | **Listing Exchange** | Shenzhen Stock Exchange | | **Company Name** | Guiyang Longma Information Technology Co., Ltd | | **Legal Representative** | Wang Wei | [Key Accounting Data and Financial Indicators](index=6&type=section&id=%E5%9B%9B%E3%80%81%E4%B8%BB%E8%A6%81%E4%BC%9A%E8%AE%A1%E6%95%B0%E6%8D%AE%E5%92%8C%E8%B4%A2%E5%8A%A1%E6%8C%87%E6%A0%87) In the first half of 2019, the company's total operating revenue was 234 million Yuan, a 2.50% year-on-year increase, but net profit attributable to shareholders decreased by 12.13% to 44.05 million Yuan, while net cash flow from operating activities showed strong growth of 54.66% | Indicator | Current Period (Yuan) | Prior Year Period (Yuan) | Year-on-Year Change | | :--- | :--- | :--- | :--- | | **Total Operating Revenue** | 234,188,485.73 | 228,472,570.81 | 2.50% | | **Net Profit Attributable to Shareholders** | 44,054,404.71 | 50,134,370.92 | -12.13% | | **Net Profit Attributable to Shareholders (Excluding Non-Recurring Items)** | 41,165,592.12 | 45,049,662.52 | -8.62% | | **Net Cash Flow from Operating Activities** | 65,494,407.15 | 42,348,247.01 | 54.66% | | **Basic Earnings Per Share (Yuan/share)** | 0.13 | 0.15 | -13.33% | | **Weighted Average Return on Net Assets** | 3.30% | 4.05% | -0.75% | | **Total Assets** | 1,775,845,075.20 | 1,722,366,727.60 | 3.10% (vs. end of prior year) | | **Net Assets Attributable to Shareholders** | 1,345,228,702.66 | 1,318,071,368.05 | 2.06% (vs. end of prior year) | [Non-Recurring Gains and Losses Items and Amounts](index=7&type=section&id=%E5%85%AD%E3%80%81%E9%9D%9E%E7%BB%8F%E5%B8%B8%E6%80%A7%E6%8D%9F%E7%9B%8A%E9%A1%B9%E7%9B%AE%E5%8F%8A%E9%87%91%E9%A2%9D) During the reporting period, the company's total non-recurring gains and losses amounted to 2.89 million Yuan, primarily from government subsidies of 3.28 million Yuan recognized in current profit or loss | Item | Amount (Yuan) | Explanation | | :--- | :--- | :--- | | Government subsidies recognized in current profit or loss | 3,277,592.42 | Primarily for the current period's allocation of prior government subsidies and current period's income-related subsidies | | Debt restructuring gains and losses | 229,291.48 | Sixi Hospital received creditor waivers | | **Total** | **2,888,812.59** | -- | [Business Overview](index=9&type=section&id=%E7%AC%AC%E4%B8%89%E8%8A%82%20%E5%85%AC%E5%8F%B8%E4%B8%9A%E5%8A%A1%E6%A6%82%E8%A6%81) [Principal Businesses](index=9&type=section&id=%E4%B8%80%E3%80%81%E6%8A%A5%E5%91%8A%E6%9C%9F%E5%86%85%E5%85%AC%E5%8F%B8%E4%BB%8E%E4%BA%8B%E7%9A%84%E4%B8%BB%E8%A6%81%E4%B8%9A%E5%8A%A1) The company's operations are primarily divided into two segments: medical + internet medical services and telecommunications & value-added telecommunications services, with the latter experiencing revenue decline due to operator structural adjustments - Company's core strategy is to deeply cultivate the medical + internet medical business, leveraging physical medical institutions and internet/big data technologies to build a closed-loop medical service of online services + offline hospitals[27](index=27&type=chunk) - The medical business segment has a broad layout, including: physical medical institutions (Guiyang Sixi Hospital), medical information services (39 Health Network), internet hospitals, IPTV smart healthcare, smart wearable devices, and pharmaceutical distribution[27](index=27&type=chunk)[28](index=28&type=chunk)[30](index=30&type=chunk) - In the telecommunications and value-added telecommunications business segment, the "Phone Duet" business experienced reduced operating regions and revenue decline due to operator business structure adjustments[37](index=37&type=chunk) [Significant Changes in Major Assets](index=11&type=section&id=%E4%BA%8C%E3%80%81%E4%B8%BB%E8%A6%81%E8%B5%84%E4%BA%A7%E9%87%8D%E5%A4%A7%E5%8F%98%E5%8C%96%E6%83%85%E5%86%B5) During the reporting period, there were no extreme significant changes in the company's major assets, with long-term equity investments, prepayments, and notes receivable showing notable increases | Major Asset | Change from Beginning of Year | Explanation of Change | | :--- | :--- | :--- | | **Long-term Equity Investments** | +7.52% | Capital increase in Sanjiu Medical by Qisheng Information and equity method accounting for investment income | | **Notes Receivable** | +45.76% | Increase in bank acceptance bills received by Qisheng Information | | **Prepayments** | +57.97% | Prepayments for engineering by Sixi Hospital and prepayments for telecom settlement by Longma Communication | | **Other Non-current Assets** | +352.47% | Increase in prepayments for medical equipment purchases by Sixi Hospital | [Analysis of Core Competencies](index=12&type=section&id=%E4%B8%89%E3%80%81%E6%A0%B8%E5%BF%83%E7%AB%9E%E4%BA%89%E5%8A%9B%E5%88%86%E6%9E%90) The company's core competencies span internet medical services, internet information services, pharmaceutical distribution, and voice value-added services, underpinned by policy support, professional teams, and established networks - Internet medical core competency: Respecting the essence of medicine, using the internet as an "amplifier" and "connector" for high-quality medical resources[40](index=40&type=chunk) - Internet information service core competency: 39 Health Network, as a leading domestic health portal, possesses advantages in network scale, content, cooperation resources, and talent[41](index=41&type=chunk) - Policy support: The big data and big health industries, in which the company operates, are pillar industries in Guizhou Province, receiving strong support from various levels of provincial government[40](index=40&type=chunk) [Management Discussion and Analysis](index=14&type=section&id=%E7%AC%AC%E5%9B%9B%E8%8A%82%20%E7%BB%8F%E8%90%A5%E6%83%85%E5%86%B5%E8%AE%A8%E8%AE%BA%E4%B8%8E%E5%88%86%E6%9E%90) [Overview of Operations](index=14&type=section&id=%E4%B8%80%E3%80%81%E6%A6%82%E8%BF%B0) In the first half of 2019, the company deepened its "Internet + Medical" strategy, forming a health service closed-loop based on physical hospitals, with medical information and services as primary revenue sources, while traditional telecom services declined - The company, as the lead unit, established the Medical and Health Big Data Professional Committee of the National Technical Standard Innovation Base (Guizhou Big Data), dedicated to establishing industry standards[46](index=46&type=chunk) Business Segment Operating Performance | Business Segment | Revenue for the Period (million Yuan) | Year-on-Year Change | Operating Highlights | | :--- | :--- | :--- | :--- | | **39 Health Network** | 83.21 | +9.47% | Achieved a shift from traffic monetization to "service + content" monetization | | **Physical Hospital (Guiyang Sixi Hospital)** | 98.67 | +17.79% | Significant growth in outpatient, inpatient, and surgical volumes, with continuous operational improvement | | **39 Internet Hospital** | - | - | Collaborated with over 300 county-level hospitals, completing over 200,000 case diagnoses and treatments | | **Pharmaceutical Distribution (Pharmaceutical E-commerce)** | 1,271.91 | -18.9% | Profitability weakened due to the "Two-Invoice System" | | **Phone Duet** | 24.84 | -45.31% | Business regions reduced due to operator business adjustments | | **Mobile Resale** | 23.65 | +9.5% | Stable business development | [Analysis of Principal Business](index=19&type=section&id=%E4%BA%8C%E3%80%81%E4%B8%BB%E8%90%A5%E4%B8%9A%E5%8A%A1%E5%88%86%E6%9E%90) During the reporting period, the company's total operating revenue slightly increased by 2.50%, but rising operating costs led to a decline in gross profit margin, while sales expenses significantly decreased and financial expenses increased Key Financial Data Year-on-Year Change | Item | Current Period (Yuan) | Prior Year Period (Yuan) | Year-on-Year Change | | :--- | :--- | :--- | :--- | | **Operating Revenue** | 234,188,485.73 | 228,472,570.81 | 2.50% | | **Operating Cost** | 124,006,039.17 | 108,526,490.67 | 14.26% | | **Selling Expenses** | 6,877,400.51 | 12,113,558.98 | -43.23% | | **Financial Expenses** | 2,576,435.87 | 1,522,198.28 | 69.26% | | **Net Cash Flow from Operating Activities** | 65,494,407.15 | 42,348,247.01 | 54.66% | By Product or Service | Product/Service | Operating Revenue (Yuan) | Gross Margin | Year-on-Year Change in Operating Revenue | | :--- | :--- | :--- | :--- | | **Phone Duet & Duet Coins** | 24,837,621.38 | 83.87% | -45.31% | | **Mobile Resale Business** | 23,647,447.84 | 41.62% | 9.51% | | **Medical Information Services** | 82,152,848.64 | 79.57% | 10.87% | | **Medical Services** | 96,617,309.97 | 10.93% | 17.00% | [Analysis of Non-Principal Business](index=20&type=section&id=%E4%B8%89%E3%80%81%E9%9D%9E%E4%B8%BB%E8%90%A5%E4%B8%9A%E5%8A%A1%E5%88%86%E6%9E%90) During the reporting period, non-principal businesses significantly impacted total profit, with investment income from equity method accounting being sustainable, while government subsidies were non-recurring | Item | Amount (Yuan) | Percentage of Total Profit | Reason for Formation | | :--- | :--- | :--- | :--- | | **Investment Income** | 9,903,974.52 | 18.82% | Investment income from equity method accounting for associate companies | | **Other Income** | 3,277,592.42 | 6.23% | Government subsidies related to daily business activities | [Analysis of Assets and Liabilities](index=20&type=section&id=%E5%9B%9B%E3%80%81%E8%B5%84%E4%BA%A7%E3%80%81%E8%B4%9F%E5%80%BA%E7%8A%B6%E5%86%B5%E5%88%86%E6%9E%90) As of the end of the reporting period, the company's total assets increased by 3.10% to 1.78 billion Yuan, with a notable increase in long-term borrowings and some bank accounts of a subsidiary being frozen due to a construction contract dispute - Long-term borrowings significantly increased compared to the end of the previous year, with their proportion of total assets rising from 1.22% to **6.03%**, primarily due to the parent company obtaining a three-year long-term loan from Industrial Bank[70](index=70&type=chunk) - Guiyang Sixi Hospital Co., Ltd., a controlled subsidiary, had some bank accounts frozen due to a construction engineering contract dispute, with the frozen amount totaling **18,704,165.64 Yuan** at period-end, though this did not affect its daily operations[71](index=71&type=chunk) [Analysis of Investment Status](index=21&type=section&id=%E4%BA%94%E3%80%81%E6%8A%95%E8%B5%84%E7%8A%B6%E5%86%B5%E5%88%86%E6%9E%90) During the reporting period, the company's investment decreased by 42.95% to 12.20 million Yuan, with the only significant equity investment being the acquisition of a 1.93% stake in Guiyang Sanjiu Internet Medical Co., Ltd - A significant equity investment occurred during the reporting period: Guangzhou Qisheng Information Technology Co., Ltd., a wholly-owned subsidiary, used **12.20 million Yuan** of its own funds to acquire a **1.93%** equity stake in Guiyang Sanjiu Internet Medical Co., Ltd[74](index=74&type=chunk) [Analysis of Major Holding and Associate Companies](index=24&type=section&id=%E4%B8%83%E3%80%81%E4%B8%BB%E8%A6%81%E6%8E%A7%E8%82%A1%E5%8F%82%E8%82%A1%E5%85%AC%E5%8F%B8%E5%88%86%E6%9E%90) During the reporting period, Guangzhou Qisheng Information Technology Co., Ltd. (39 Health Network) was the primary profit contributor, while Guiyang Sixi Hospital Co., Ltd. incurred a loss despite significant revenue Major Holding and Associate Company Performance (H1 2019) | Company Name | Type | Operating Revenue (Yuan) | Net Profit (Yuan) | | :--- | :--- | :--- | :--- | | **Guangzhou Qisheng Information Technology Co., Ltd.** | Subsidiary | 83,214,345.22 | 43,364,252.10 | | **Guiyang Sixi Hospital Co., Ltd.** | Subsidiary | 98,668,360.85 | -3,850,971.80 | | **Guiyang Longma Communication Technology Co., Ltd.** | Subsidiary | 23,647,447.84 | 7,354,332.34 | | **Guiyang Pharmaceutical E-commerce Service Co., Ltd.** | Associate Company | 1,271,911,528.26 | 28,717,578.57 | - The company completed the deregistration of its wholly-owned subsidiary "Guiyang Longma Development Investment and Property Co., Ltd." in June 2019, which had no actual capital contribution or operations, thus the deregistration has no impact on the company[83](index=83&type=chunk)[84](index=84&type=chunk) [Risks and Countermeasures](index=25&type=section&id=%E5%8D%81%E3%80%81%E5%85%AC%E5%8F%B8%E9%9D%A2%E4%B8%B4%E7%9A%84%E9%A3%8E%E9%99%A9%E5%92%8C%E5%BA%94%E5%AF%B9%E6%8E%AA%E6%96%BD) The company faces risks from intensified market competition, policy changes, traditional telecom business adjustments, management challenges from asset expansion, and goodwill impairment, addressed through continuous innovation and strategic adjustments - Market competition risk: The internet medical industry is experiencing an influx of capital and increasing competition, requiring the company to maintain leadership in R&D, technology, and business models[85](index=85&type=chunk) - Industry policy risk: The healthcare industry is highly influenced by policies and regulations, exposing the company to risks of stricter supervision[86](index=86&type=chunk) - Telecom business adjustment risk: The "Phone Duet" business experienced a significant revenue decline due to operator structural adjustments, prompting the company to reallocate resources to other businesses[87](index=87&type=chunk) - Goodwill impairment risk: The company has significant goodwill from acquisitions, and a decline in the performance of acquired companies could lead to goodwill impairment[88](index=88&type=chunk) [Significant Matters](index=27&type=section&id=%E7%AC%AC%E4%BA%94%E8%8A%82%20%E9%87%8D%E8%A6%81%E4%BA%8B%E9%A1%B9) [Litigation Matters](index=33&type=section&id=%E5%85%AB%E3%80%81%E8%AF%89%E8%AE%BC%E4%BA%8B%E9%A1%B9) During the reporting period, the company had no major litigation or arbitration matters, but a subsidiary was involved in a construction contract dispute with an outstanding amount of 21.79 million Yuan - Guiyang Sixi Hospital Co., Ltd., a controlled subsidiary, is involved in a construction engineering contract dispute with an amount of **21.79 million Yuan**, and the case is still pending[101](index=101&type=chunk) [Significant Related Party Transactions](index=34&type=section&id=%E5%8D%81%E4%B8%89%E3%80%81%E9%87%8D%E5%A4%A7%E5%85%B3%E8%81%94%E4%BA%A4%E6%98%93) During the reporting period, the company's significant related party transactions primarily involved purchases related to daily operations, with Guiyang Sixi Hospital procuring drugs and medical consumables from Guiyang Pharmaceutical E-commerce Service Co., Ltd Related Party Transactions in Ordinary Course of Business | Related Party | Related Party Transaction Content | Related Party Transaction Amount (million Yuan) | | :--- | :--- | :--- | | Guiyang Pharmaceutical E-commerce Service Co., Ltd | Purchase of drugs, medical consumables, etc | 21.50 | | Guiyang Sanjiu Internet Medical Co., Ltd | Website maintenance and labor services | 2.60 | [Significant Contracts and Their Performance](index=36&type=section&id=%E5%8D%81%E5%9B%9B%E3%80%81%E9%87%8D%E5%A4%A7%E5%90%88%E5%90%8C%E5%8F%8A%E5%85%B6%E5%B1%A5%E8%A1%8C%E6%83%85%E5%86%B5) During the reporting period, the company had external guarantees exclusively for its subsidiaries, with an actual outstanding balance of 287 million Yuan, representing 21.33% of the company's net assets Company Guarantee Status (As of End of Reporting Period) | Guarantee Type | Total Approved Guarantee Limit (million Yuan) | Total Actual Guarantee Balance (million Yuan) | | :--- | :--- | :--- | | **Guarantees for Subsidiaries** | 770 | 287 | [Social Responsibility](index=39&type=section&id=%E5%8D%81%E4%BA%94%E3%80%81%E7%A4%BE%E4%BC%9A%E8%B4%A3%E4%BB%BB%E6%83%85%E5%86%B5) The company actively fulfills its social responsibilities, particularly in targeted poverty alleviation, by investing 115 thousand Yuan in educational and medical assistance projects in Guizhou during the first half of 2019 - The company actively participated in the "Hundred Enterprises Helping Hundred Villages" poverty alleviation initiative, investing **20 thousand Yuan** in funds and **95 thousand Yuan** in materials for education and health poverty alleviation in the first half of 2019[123](index=123&type=chunk)[124](index=124&type=chunk)[125](index=125&type=chunk) [Share Changes and Shareholder Information](index=43&type=section&id=%E7%AC%AC%E5%85%AD%E8%8A%82%20%E8%82%A1%E4%BB%BD%E5%8F%98%E5%8A%A8%E5%8F%8A%E8%82%A1%E4%B8%9C%E6%83%85%E5%86%B5) [Share Changes](index=43&type=section&id=%E4%B8%80%E3%80%81%E8%82%A1%E4%BB%BD%E5%8F%98%E5%8A%A8%E6%83%85%E5%86%B5) During the reporting period, the company's total share capital of 337,941,402 shares remained unchanged, with a minor adjustment in share structure due to the release of restricted shares held by a former senior executive - During the reporting period, due to Mr. Shi Hongjun's departure for over half a year, his **1,560,000 restricted shares** for senior executives were released from restrictions, leading to a decrease in restricted shares and a corresponding increase in unrestricted shares[136](index=136&type=chunk) [Number of Shareholders and Shareholding Status](index=44&type=section&id=%E4%B8%89%E3%80%81%E5%85%AC%E5%8F%B8%E8%82%A1%E4%B8%9C%E6%95%B0%E9%87%8F%E5%8F%8A%E6%8C%81%E8%82%A1%E6%83%85%E5%86%B5) As of the end of the reporting period, the company had 35,859 common shareholders, with the top three being natural persons, and the controlling shareholder and his concerted parties holding a significant combined stake Top Ten Shareholders' Shareholding Status (As of June 30, 2019) | Shareholder Name | Shareholding Percentage | Number of Shares Held (shares) | | :--- | :--- | :--- | | **Wang Wei** | 35.56% | 120,185,915 | | **Jin Guowen** | 7.11% | 24,036,100 | | **Huang Guohong** | 5.91% | 19,981,086 | | **Liu Ling** | 4.53% | 15,312,900 | | **Guiyang Longma Investment Consulting Enterprise (Limited Partnership)** | 2.45% | 8,285,640 | - Guiyang Longma Investment Consulting Enterprise (Limited Partnership), a corporate shareholder, is controlled by the company's controlling shareholder and actual controller, Wang Wei, and they are concerted parties[142](index=142&type=chunk) [Preferred Shares Information](index=48&type=section&id=%E7%AC%AC%E4%B8%83%E8%8A%82%20%E4%BC%98%E5%85%88%E8%82%A1%E7%9B%B8%E5%85%B3%E6%83%85%E5%86%B5) [Preferred Shares Information](index=48&type=section&id=%E4%BC%98%E5%85%88%E8%82%A1%E7%9B%B8%E5%85%B3%E6%83%85%E5%86%B5) During the reporting period, the company had no preferred shares - The company had no preferred shares during the reporting period[148](index=148&type=chunk) [Directors, Supervisors, and Senior Management](index=49&type=section&id=%E7%AC%AC%E5%85%AB%E8%8A%82%20%E8%91%A3%E4%BA%8B%E3%80%81%E7%9B%91%E4%BA%8B%E3%80%81%E9%AB%98%E7%BA%A7%E7%AE%A1%E7%90%86%E4%BA%BA%E5%91%98%E6%83%85%E5%86%B5) [Changes in Shareholdings of Directors, Supervisors, and Senior Management](index=49&type=section&id=%E4%B8%80%E3%80%81%E8%91%A3%E4%BA%8B%E3%80%81%E7%9B%91%E4%BA%8B%E5%92%8C%E9%AB%98%E7%BA%A7%E7%AE%A1%E7%90%86%E4%BA%BA%E5%91%98%E6%8C%81%E8%82%A1%E5%8F%98%E5%8A%A8) During the reporting period, Chairman Wang Wei reduced his shareholding by 2,310,085 shares, while other directors, supervisors, and senior management had no changes in their shareholdings | Name | Position | Number of Shares Reduced in Current Period (shares) | Number of Shares Held at Period-End (shares) | | :--- | :--- | :--- | :--- | | **Wang Wei** | Chairman | 2,310,085 | 120,185,915 | [Changes in Directors, Supervisors, and Senior Management Personnel](index=50&type=section&id=%E4%BA%8C%E3%80%81%E5%85%AC%E5%8F%B8%E8%91%A3%E4%BA%8B%E3%80%81%E7%9B%91%E4%BA%8B%E3%80%81%E9%AB%98%E7%BA%A7%E7%AE%A1%E7%90%86%E4%BA%BA%E5%91%98%E5%8F%98%E5%8A%A8%E6%83%85%E5%86%B5) During the reporting period, the company appointed Tian Dan as Deputy General Manager and terminated the employment of Deputy General Manager Pan Nianhua due to health reasons - The company appointed Tian Dan as Deputy General Manager on January 7, 2019[153](index=153&type=chunk) - The company terminated Pan Nianhua's position as Deputy General Manager on April 18, 2019, due to health reasons preventing normal performance of duties[153](index=153&type=chunk) [Corporate Bonds Information](index=51&type=section&id=%E7%AC%AC%E4%B9%9D%E8%8A%82%20%E5%85%AC%E5%8F%B8%E5%80%BA%E7%9B%B8%E5%85%B3%E6%83%85%E5%86%B5) [Corporate Bonds Information](index=51&type=section&id=%E5%85%AC%E5%8F%B8%E5%80%BA%E7%9B%B8%E5%85%B3%E6%83%85%E5%86%B5) During the reporting period, the company had no publicly issued and listed corporate bonds on a stock exchange that were either unexpired or not fully redeemed by the approval date of the semi-annual report - The company has no unexpired or unredeemed corporate bonds[156](index=156&type=chunk) [Financial Report](index=52&type=section&id=%E7%AC%AC%E5%8D%81%E8%8A%82%20%E8%B4%A2%E5%8A%A1%E6%8A%A5%E5%91%8A) [Financial Statements](index=52&type=section&id=%E4%BA%8C%E3%80%81%E8%B4%A2%E5%8A%A1%E6%8A%A5%E8%A1%A8) This section presents the company's unaudited consolidated and parent company financial statements for the first half of 2019, including the balance sheet, income statement, cash flow statement, and statement of changes in owners' equity - The company's semi-annual financial report is unaudited[158](index=158&type=chunk) [Consolidated Balance Sheet](index=52&type=section&id=1%E3%80%81%E5%90%88%E5%B9%B6%E8%B5%84%E4%BA%A7%E8%B4%9F%E5%80%BA%E8%A1%A8) As of June 30, 2019, the company's total assets were 1.78 billion Yuan, total liabilities were 375 million Yuan, and owners' equity attributable to the parent company was 1.35 billion Yuan, resulting in a debt-to-asset ratio of 21.12% Consolidated Balance Sheet Key Items (June 30, 2019) | Item | Amount (Yuan) | | :--- | :--- | | **Total Assets** | 1,775,845,075.20 | | **Total Liabilities** | 375,125,987.71 | | **Total Owners' Equity Attributable to Parent Company** | 1,345,228,702.66 | | **Total Owners' Equity** | 1,400,719,087.49 | [Consolidated Income Statement](index=58&type=section&id=3%E3%80%81%E5%90%88%E5%B9%B6%E5%88%A9%E6%B6%A6%E8%A1%A8) In the first half of 2019, the company achieved total operating revenue of 234 million Yuan, total operating costs of 194 million Yuan, total profit of 52.64 million Yuan, and net profit of 44.00 million Yuan, with 44.05 million Yuan attributable to parent company owners Consolidated Income Statement Key Items (H1 2019) | Item | Amount (Yuan) | | :--- | :--- | | **Total Operating Revenue** | 234,188,485.73 | | **Operating Profit** | 52,423,166.51 | | **Total Profit** | 52,637,175.70 | | **Net Profit** | 44,004,226.45 | | **Net Profit Attributable to Parent Company Owners** | 44,054,404.71 | [Consolidated Cash Flow Statement](index=63&type=section&id=5%E3%80%81%E5%90%88%E5%B9%B6%E7%8E%B0%E9%87%91%E6%B5%81%E9%87%8F%E8%A1%A8) In the first half of 2019, the company's net cash flow from operating activities was 65.49 million Yuan, net cash flow from investing activities was -42.85 million Yuan, and net cash flow from financing activities was -21.80 million Yuan, resulting in a net increase in cash and cash equivalents of 848.6 thousand Yuan Consolidated Cash Flow Statement Key Items (H1 2019) | Item | Amount (Yuan) | | :--- | :--- | | **Net Cash Flow from Operating Activities** | 65,494,407.15 | | **Net Cash Flow from Investing Activities** | -42,846,122.60 | | **Net Cash Flow from Financing Activities** | -21,799,681.98 | | **Net Increase in Cash and Cash Equivalents** | 848,602.57 | [Documents Available for Inspection](index=178&type=section&id=%E7%AC%AC%E5%8D%81%E4%B8%80%E8%8A%82%20%E5%A4%87%E6%9F%A5%E6%96%87%E4%BB%B6%E7%9B%AE%E5%BD%95)
朗玛信息:关于参加2019年贵州上市公司投资者网上集体接待日活动的公告
2019-05-30 09:20
证券代码:300288 证券简称:朗玛信息 公告编号:2019-026 贵阳朗玛信息技术股份有限公司 活动的公告 关于参加2019年贵州上市公司投资者网上集体接待日 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 为便于广大投资者更深入全面地了解贵阳朗玛信息技术股份有限公司 (以下简称"公司")情况、发展战略、经营状况、可持续发展等投资者 所关心的问题,公司定于 2019 年 6 月 5 日下午 14:00-17:00 参加由贵州证 监局主办,贵州证券业协会、深圳市全景网络有限公司协办的主题为"股 东来了——构建和谐投资者关系"2019 年贵州上市公司投资者网上集体接 待日活动。现将有关事项公告如下: 本次集体接待日网上交流网址:投资者可以登录 http://rs.p5w.net 进入专区页面参与交流。 出席本次集体接待日的人员有:公司董事会秘书兼财务总监王春女士, 证券事务代表肖越越女士。 欢迎广大投资者积极参与。 特此公告。 贵阳朗玛信息技术股份有限公司董事会 2019 年 5 月 30 日 ...